5-Amino-2-(4-tert-butylphenoxy)pyridine is an organic compound characterized by its pyridine ring, which is substituted at the 2-position with a phenoxy group that contains a tert-butyl group at the para position. This structure imparts unique properties, including potential lipophilicity due to the bulky tert-butyl group, which can influence its solubility and interaction with biological systems. The amino group at the 5-position can participate in hydrogen bonding, enhancing its reactivity and potential as a ligand in coordination chemistry. This compound may exhibit biological activity, making it of interest in pharmaceutical research, particularly in the development of new therapeutic agents. Its molecular structure suggests it could interact with various biological targets, potentially influencing pathways related to cell signaling or enzyme inhibition. Additionally, the presence of both hydrophilic (amino) and hydrophobic (tert-butyl) regions may contribute to its pharmacokinetic properties, affecting absorption, distribution, metabolism, and excretion (ADME) profiles. Overall, 5-Amino-2-(4-tert-butylphenoxy)pyridine is a compound of interest in both synthetic and medicinal chemistry.

5-Amino-2-(4-tertbutylphenoxy)pyridine

218457-67-1: 3-Pyridinamine, 6-[4-(1,1-Dimethylethyl)Phenoxy]-, 6-(4-tert-Butylphenoxy)pyridin-3-amine

6-(4-(tert-Butyl)phenoxy)pyridin-3-amine

CB-103

CB-103 is a orally active inhibitor of notch signaling pathway, with anti-tumor activity.

6-[4-(tert-Butyl)phenoxy]pyridin-3-amine

6-[4-(tert-Butyl)phenoxy]pyridin-3-amine is a novel cancer drug that belongs to the class of drugs called microsatellite inhibitors. It inhibits DNA synthesis by binding to the estrogen receptor, which prevents the receptor from activating DNA synthesis and cell division. 6-[4-(tert-Butyl)phenoxy]pyridin-3-amine has been shown to be effective against paclitaxel-resistant tumor cells and may be useful in combination with other chemotherapy drugs such as doxorubicin or vincristine. This drug also causes genetic damage in cultured human myelodysplastic cells, but not in healthy human lymphocytes.

CAS 218457-67-1: 5-Amino-2-(4-tertbutylphenoxy)pyridine

6-(4-(tert-Butyl)phenoxy)pyridin-3-amine

Ref: IN-DA007P2N

CB-103

Ref: 54-BUP17541

CB-103

Ref: TM-T12246

6-[4-(tert-Butyl)phenoxy]pyridin-3-amine

Ref: 54-OR8051

6-[4-(tert-Butyl)phenoxy]pyridin-3-amine

Ref: 3D-TIA45767